Total investments received (USD): 14.78m
Round value (USD): N/A
Company: Visiopharm
Industry:
Health services



Belgium
Netherlands
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain